VarCT Diagnostics ApS
Private limited companyCVR 38733567FrederiksbergActive
VarCT Diagnostics ApS is a private limited company, based in Frederiksberg, active in research and experimental development on natural sciences and engineering, founded in 2017. The company went from a profit in 2024 to a loss of DKK 2m in 2025. Equity fell to DKK 2.2m in 2025. 8 other companies in the database are registered at the same address.
Key figures · financial year 2025
What has changed
calculated from recorded figures and datesFinancials: 2025 against 2024
- Gross profit fell 95% (2024 → 2025), to DKK 177k.
- Net profit went from a profit of DKK 779k to a loss of DKK 2m (2024 → 2025).
- Equity fell 47% (2024 → 2025), to DKK 2.2m.
Employees
- 2 fewer employees than a year earlier: 6 (07/2026) against 8 (07/2025).
Registrations, last 24 months
- 01/01/2025: Industry changed to Research and experimental development on natural sciences and engineering (721000)
Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.
Financial statements
Financial years 2020–2025 · amounts in DKK thousandEquity and net profit
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change | |
|---|---|---|---|---|---|---|---|
| Revenue | not stated | not stated | not stated | not stated | not stated | not stated | – |
| Gross profit | 1,175 | −483 | 89 | 442 | 3,425 | 177 | −94.8% |
| Operating profit (EBIT) | −1,003 | −2,133 | −2,555 | −2,280 | 528 | −2,605 | −593.3% |
| Profit before tax | −1,014 | −2,141 | −2,533 | −2,066 | 779 | −2,423 | −410.9% |
| Net profit | −761 | −1,746 | −1,930 | −1,645 | 779 | −1,961 | −351.7% |
| Total assets | 10,266 | 10,562 | 6,884 | 6,405 | 5,668 | 10,152 | +79.1% |
| Equity | 8,742 | 6,996 | 5,065 | 3,421 | 4,200 | 2,238 | −46.7% |
| Liabilities | 1,524 | 3,566 | 1,818 | 2,984 | 1,469 | 7,914 | +438.9% |
| Cash and cash equivalents | 6,859 | 7,783 | 3,382 | 2,533 | 1,092 | 5,503 | +404.2% |
| Average number of employees | 3 | 2 | 4 | 5 | 5 | 5 | 0% |
Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.
Download the figures as CSV · free with an account, amounts in whole DKK
Signals from the financial statements
calculated from the 2025 figuresEquity fell sharply
Equity fell 47% from 2024 to 2025 (DKK 4.2m to DKK 2.2m).
How is this calculated?
Equity has fallen by at least 30% from the previous annual report, and it was positive the year before.
The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.
Annual reports
6 financial years| Financial year | Period | Published | Figures for | Documents |
|---|---|---|---|---|
| 2025 | 01/01/2025 – 31/12/2025 | 08/06/2026 | The company | PDF not statedXBRL |
| 2024 | 01/01/2024 – 31/12/2024 | 27/05/2025 | The company | PDFXBRL |
| 2023 | 01/01/2023 – 31/12/2023 | 27/05/2024 | The company | PDFXBRL |
| 2022 | 01/01/2022 – 31/12/2022 | 02/06/2023 | The company | PDFXBRL |
| 2021 | 01/01/2021 – 31/12/2021 | 08/04/2022 | The company | PDFXBRL |
| 2020 | 01/01/2020 – 31/12/2020 | 28/06/2021 | The company | PDFXBRL |
The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.
Employees
monthly figures from CVRPosition in the industry
431 companies in the databaseComparison with the other companies in research and experimental development on natural sciences and engineering based on the latest financial year.
Industry median: gross profit DKK 616k, net profit −DKK 892k, equity DKK 2m, 5 employees.
Compared with similar companies
size, age and company form| Group | Gross profit | Equity |
|---|---|---|
| Companies with fewer than 20 employees69,967 companies in the comparison | No. 59,817of 69,742 Better than 14% | No. 22,892of 69,964 Better than 67% |
| Same industry and fewer than 20 employees329 companies in the comparison | No. 164of 323 Better than 49% | No. 125of 329 Better than 62% |
| Companies that are between 5 and 14 years old33,679 companies in the comparison | No. 29,832of 33,579 Better than 11% | No. 10,129of 33,678 Better than 70% |
| All companies of type ApS66,508 companies in the comparison | No. 57,533of 66,379 Better than 13% | No. 19,154of 66,505 Better than 71% |
The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.
Compare with the industry
Research and experimental development on natural sciences and engineering- VarCT Diagnostics ApSDKK 177k
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- VarCT Diagnostics ApS−DKK 2m
- Carlsberg A/SDKK 7bn
- Zealand Pharma A/SDKK 6.5bn
- VarCT Diagnostics ApSDKK 2.2m
- Carlsberg A/SDKK 30.7bn
- Zealand Pharma A/SDKK 14.8bn
- VarCT Diagnostics ApS6
- Carlsberg A/S107
- Zealand Pharma A/S569
Latest financial year per company. Choose up to three companies from the largest in the industry.
Owners and group
from the Public Ownership Register- Var2 Pharmaceuticals ApS66.67%
- Sitour Management m.b.H.20%
Management
8 active registrationsExecutive management
| Name | Role | Appointed |
|---|---|---|
| Ali El-Salanti | Director | 20/06/2017 |
| Mads Daugaard | Director | 20/06/2017 |
Board of directors
| Name | Role | Appointed |
|---|---|---|
| Ali El-Salanti | Board member | 20/06/2017 |
| Mads Daugaard | Chair of the board | 20/06/2017 |
| Peter Schröcksnadel | Board member | 20/06/2017 |
| Thor Grundtvig Theander | Board member | 01/04/2022 |
| Josef Rainer | Board member | 01/04/2022 |
| Poul Henrik Bredahl Sørensen | Board member | 01/04/2022 |
- Founders
- Var2 Pharmaceuticals ApS
Former management (1)
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| Ulf Andreas Linderoth Norlin | Director | 18/01/2018 | 31/03/2020 |
Signing rule: Selskabet tegnes af bestyrelsens formand i forening med et bestyrelsesmedlem eller en direktør eller af den samlede bestyrelse.
Address and production units
1 active production unitsNordre Fasanvej 215
2000 Frederiksberg
Frederiksberg Municipality · Postcode 2000
Other companies at the address (8)
- Sparrow Quantum ApSManufacture of computers and peripheral equipment
- Adcendo ApSResearch and experimental development on natural sciences and engineering
- Hemab ApSManufacture of pharmaceutical preparations
- Orbis Medicines ApSResearch and experimental development on natural sciences and engineering
- Minervax ApSResearch and experimental development on natural sciences and engineering
| Production unit | Address | Employees | P number |
|---|---|---|---|
| VarCT Diagnostics ApS | Nordre Fasanvej 215, 2000 Frederiksberg | 7 | 1022556165 |
Purpose
Selskabets formål er, direkte eller via besiddelse af kapitalandele i andre selskaber, at drive virksomhed inden for kræftdiagnosticering og -bekæmpelse samt anden virksomhed, der efter bestyrelsens skøn er forbundet dermed.
The purpose is quoted from the register in Danish.
Changes year by year
26 registered events20261 changeaccounts 1
- AccountsAnnual report for 2025 published
20252 changesaccounts 1 · industry 1
- AccountsAnnual report for 2024 published
- IndustryIndustry changed to Research and experimental development on natural sciences and engineering (721000)
20242 changesaccounts 1 · address 1
- AccountsAnnual report for 2023 published
- AddressMoved to Nordre Fasanvej 215, 2000 Frederiksberg
20231 changeaccounts 1
- AccountsAnnual report for 2022 published
20224 changesaccounts 1 · management 3
- AccountsAnnual report for 2021 published
- ManagementThor Grundtvig Theander appointed board member
- ManagementPoul Henrik Bredahl Sørensen appointed board member
- ManagementJosef Rainer appointed board member
20211 changeaccounts 1
- AccountsAnnual report for 2020 published
20201 changemanagement 1
- ManagementUlf Andreas Linderoth Norlin stepped down as director
20186 changescapital 1 · ownership 4 · management 1
- CapitalShare capital changed from 50,000 DKK to 56,250 DKK
- OwnershipVAR2 PHARMACEUTICALS ApS registered as owner (66.67%)
- OwnershipSitour Management m.b.H. registered as owner (20%)
- OwnershipVAR2 PHARMACEUTICALS ApS is no longer registered as owner
- OwnershipSitour Management m.b.H. is no longer registered as owner
- ManagementUlf Andreas Linderoth Norlin appointed director
20178 changesfounded 1 · management 5 · ownership 2
- FoundedRegistered as VarCT Diagnostics ApS
- ManagementMads Daugaard appointed chair of the board
- ManagementPeter Schröcksnadel appointed board member
- ManagementMads Daugaard appointed director
- ManagementAli El-Salanti appointed board member
- ManagementAli El-Salanti appointed director
- OwnershipVAR2 PHARMACEUTICALS ApS registered as owner (90%)
- OwnershipSitour Management m.b.H. registered as owner (10%)
Related companies
Same industry in Frederiksberg
- Adcendo ApS49 employees
- Orbis Medicines ApS32 employees
- Minervax ApS28 employees
- Inprother ApS18 employees
- Acesion Pharma ApS16 employees
- Kost Studio ApS11 employees
Same people in management
- Var2 Pharmaceuticals ApSvia Ali El-Salanti
- AdaptVac ApSvia Ali El-Salanti
- FarmLaser ApSvia Mads Daugaard
Largest in the industry
- Carlsberg A/SDKK 40.2bn
- Zealand Pharma A/SDKK 9.2bn
- Gubra A/SDKK 2.6bn
- Vestas Wind Systems A/SDKK 2.5bn
- Bang & Olufsen A/SDKK 1.4bn
- 3shape A/SDKK 1.3bn
Source and updates
The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.